Transforming Ophthalmology Clinical Trial Recruitment
At Trialbee, we connect people living with vision and eye health conditions to innovative ophthalmology clinical trials designed to preserve sight, enhance independence, and improve quality of life. Through patient-centric strategies and data-driven insights, we help sponsors accelerate enrollment, support diversity, and bring sight-saving therapies to patients faster.
Key Challenges in Ophthalmology Trials
Ophthalmology studies face distinct recruitment challenges driven by slow disease progression, specialized assessments, and difficulties identifying eligible patients early. These barriers often slow enrollment and limit access to individuals who may benefit from investigational therapies.Ophthalmology studies face distinct recruitment challenges driven by slow disease progression, specialized assessments, and difficulties identifying eligible patients early. These barriers often slow enrollment and limit access to individuals who may benefit from investigational therapies.
The result: lower referral-to-randomization rates, recruitment delays, and missed opportunities to enroll qualified individuals who could benefit from emerging treatments.
Trialbee’s Solution
Trialbee delivers patient-focused, technology-driven recruitment strategies tailored to the unique needs of ophthalmology clinical trials. Our digital ecosystem integrates omnichannel outreach, medical pre-qualification, and real-time analytics to optimize enrollment speed and quality.
Precision Recruitment & Omnichannel Reach
We meet patients and caregivers where they already seek information and support — online, in patient communities, advocacy groups, and across social and healthcare networks. Leveraging behavioral insights, real-world data, and targeted digital engagement, Trialbee reaches verified, motivated individuals who are likely to meet study criteria.
Two-Stage Medical Pre-Qualification
Participants complete digital pre-screening and structured eligibility checks that incorporate ophthalmology-specific criteria such as:
- Diagnosis details and disease duration
- Visual acuity thresholds
- Prior treatments (e.g., anti-VEGF injections)
- Imaging history (OCT, angiography, etc.)
- Functional limitations and symptom progression
This ensures sites receive pre-qualified, motivated participants who understand study expectations and are prepared to take part.
Real-Time Visibility & Analytics with Honey™ Platform
Our Honey™ platform provides transparency across the entire recruitment pipeline. Sponsors and CROs can:
- Monitor referral volume and patient progression in real time
- Identify geographic and site-level bottlenecks
- Prior treatments (e.g., anti-VEGF injections)
- Optimize campaigns through performance insights
- Improve forecast accuracy using predictive analytics
Purpose-Built Creative for Ophthalmology Trials
Vision loss affects much more than eyesight — it influences independence, emotional well-being, work, social connections, and daily life. Trialbee develops empathetic, inclusive creative that:
- Honors the lived experience of individuals with low or changing
vision - Uses clear, high-contrast, accessible design principles
- Reflects both the challenges and hope surrounding emerging
eye therapies
Our creative builds trust and connection, empowering patients and caregivers to feel confident participating in ophthalmology research that may preserve sight and transform lives.
Let’s Partner for Better, Faster Recruitment
Whether you’re conducting a study in inflammatory bowel disease, liver conditions, or rare gastrointestinal disorders, Trialbee helps you connect with qualified patients — faster. Learn how our technology, data, and human-centered approach deliver measurable recruitment success.